The FDA has Announced Their Approval of Evkeeza for Homozygous Familial Hypercholesterolemia
source: pixabay.com

The FDA has Announced Their Approval of Evkeeza for Homozygous Familial Hypercholesterolemia

The FDA has just announced their approval of Evkeeza as a therapy for those living with homozygous familial hypercholesterolemia. The therapy is owned by Regeneron Pharmaceuticals. It was evaluated with…

Continue Reading The FDA has Announced Their Approval of Evkeeza for Homozygous Familial Hypercholesterolemia
Study: Familial Hypercholesterolemia is Diagnosed Late and Under-treated in US Children
source: pixabay.com

Study: Familial Hypercholesterolemia is Diagnosed Late and Under-treated in US Children

According to an announcement from the FH Foundation, data from the FH Foundation’s CASCADE FH Registry, published in The Journal of Pediatrics, has determined that children living with familial hypercholesterolemia regularly…

Continue Reading Study: Familial Hypercholesterolemia is Diagnosed Late and Under-treated in US Children

Heterozygous Familial Hypercholesterolemia Trial Shows Positive Results of Therapy in Teenagers

Researchers in Canada have just released positive results from their heterozygous familial hypercholesterolemia (HeFH) clinical trial. This investigation was examining the effect of Repatha on teenagers with the condition. The trial…

Continue Reading Heterozygous Familial Hypercholesterolemia Trial Shows Positive Results of Therapy in Teenagers
ICYMI: Good Results From Evinacumab for Rare Form of Familial Hypercholesterolemia
source: pixabay.com

ICYMI: Good Results From Evinacumab for Rare Form of Familial Hypercholesterolemia

  A press release issued recently by Regeneron Pharmaceuticals heralded the acceptance of a Biologics License Application by the FDA for Priority Review of its investigational drug, evinacumab. The Priority…

Continue Reading ICYMI: Good Results From Evinacumab for Rare Form of Familial Hypercholesterolemia
BLA for Evinacumab, a Treatment for HoFH, Receives Priority Review Status
source: pixabay.com

BLA for Evinacumab, a Treatment for HoFH, Receives Priority Review Status

  This week, Regeneron Pharmaceuticals announced that their Biologics License Application (BLA) for evanicumab, a treatment for homozygous familial hypercholesterolemia (HoFH), was granted Priority Review status by the FDA. The…

Continue Reading BLA for Evinacumab, a Treatment for HoFH, Receives Priority Review Status
Machine Learning Found to be a Better Diagnostic Tool than Dutch Lipid Score for Familial Hypercholesterolemia
source: pixabay.com

Machine Learning Found to be a Better Diagnostic Tool than Dutch Lipid Score for Familial Hypercholesterolemia

Ana Pina from the Centro de Estudos de Doencas Cronicas at NOVA Medical School in Portugal, and her colleagues recently published an innovative study regarding the diagnosis of familial hypercholesterolemia (FH).…

Continue Reading Machine Learning Found to be a Better Diagnostic Tool than Dutch Lipid Score for Familial Hypercholesterolemia
Faulty Proteins and Failed Genes: Understanding the Biology Behind Congenital Diseases
source: pixabay.com

Faulty Proteins and Failed Genes: Understanding the Biology Behind Congenital Diseases

Patients with congenital diseases often experience a range of uncomfortable symptoms. On one side of the world, a family with erythromelalgia, a painful condition which can cause redness and swelling…

Continue Reading Faulty Proteins and Failed Genes: Understanding the Biology Behind Congenital Diseases
This Drug Could be a Breakthrough for Severe Familial Hypercholesterolemia, But How Much Will it Cost?
jarmoluk / Pixabay

This Drug Could be a Breakthrough for Severe Familial Hypercholesterolemia, But How Much Will it Cost?

According to a story from Forbes, a new drug developed by the company Regeneron has the potential to make a real difference for people with the homozygous form of familial…

Continue Reading This Drug Could be a Breakthrough for Severe Familial Hypercholesterolemia, But How Much Will it Cost?
When the Latest Treatments are Out of Reach, Familial Hypercholesterolemia Patients Suffer
geralt / Pixabay

When the Latest Treatments are Out of Reach, Familial Hypercholesterolemia Patients Suffer

According to a story from FHM Pakistan, a recent study revealed the familial hypercholesterolemia patients are at a greater risk of stroke, heart attack, and other cardiovascular problems when they…

Continue Reading When the Latest Treatments are Out of Reach, Familial Hypercholesterolemia Patients Suffer
Possible Treatment for Homozygous Familial Hypercholesterolemia Earns Orphan Drug Designation
katicaj / Pixabay

Possible Treatment for Homozygous Familial Hypercholesterolemia Earns Orphan Drug Designation

According to a story from bloomberg.com, the drug development company Arrowhead Pharmaceuticals, Inc. recently announced that its experimental product candidate AR0-ANG3 has earned Orphan Drug designation from the US Food…

Continue Reading Possible Treatment for Homozygous Familial Hypercholesterolemia Earns Orphan Drug Designation
Could Blood Donations Improve Diagnostic Rates for Familial Hypercholesterolemia?
sabinurce / Pixabay

Could Blood Donations Improve Diagnostic Rates for Familial Hypercholesterolemia?

According to a story from brightsurf.com, familial hypercholesterolemia, a genetic condition that causes elevated levels of LDL cholesterol to appear at a young age, often goes undiagnosed. In fact, some…

Continue Reading Could Blood Donations Improve Diagnostic Rates for Familial Hypercholesterolemia?

Could This Revised Genetic Test Improve Diagnostic Rates for Familial Hypercholesterolemia?

According to a story from Healio, a recent study suggests that the addition of four more genes to the conventional genetic test used to diagnosed familial hypercholesterolemia could allow more…

Continue Reading Could This Revised Genetic Test Improve Diagnostic Rates for Familial Hypercholesterolemia?

Artificial Intelligence(AI) and a Solution to Detect Familial Hypercholesterolemia

  Familial Hypercholesterolemia (FH) is often misdiagnosed as plain old high cholesterol because of overlapping symptoms such as elevated lipid levels. According to a recent article in MedicalView, FH is three…

Continue Reading Artificial Intelligence(AI) and a Solution to Detect Familial Hypercholesterolemia